(+-)-Brompheniramine maleate

Specifications

980-71-2CAS Number

213-562-9EC Number

3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acidIUPAC Name

C20H23BrN2O4Chemical Formula

435.3 g/molMolecular Weight

Brompheniramine maleate; 980-71-2; Brompheniramine hydrogen maleate; Dimotane; Allent; Drauxin; Nagemid; Veltane; Ilvin; Parabromdylamine maleate; IXA7C9ZN03; Brompheniramine maleate [USP]; NSC-758652; Brompheniramine maleate (USP); CHEBI:3184; DTXSID2052657; 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate; 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (Z)-butenedioate (1:1); 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1); Dimegan; Dimotane l.a.; Brompheniramine fumarate; Maleate, Brompheniramine; RefChem:390697; Dimetapp Cold and Allergy; (+-)-Brompheniramine maleate; Brompheniramine Maleate (1:1); DTXCID3031230; CVS PHARMACY Childrens Cold and Allergy; 2-Pyridinepropanamine, gamma-(4-Bromophenyl)-N,N-dimethyl-,(Z)-butenedioate(1:1); 213-562-9; Dimetane; Dimetane-ten; (+/-)-Brompheniramine maleate; MFCD00057367; Lodrane; MLS000028423; Brompheniramine (maleate); (+/-)-Brompheniramine maleate salt; C20H23BrN2O4; Rolabromophen; Gammistin; SMR000058417; Spentane; Ebalin; 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate; MFCD00865691; Dimetane Extentabs; 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid; SR-01000003057; EINECS 213-562-9; UNII-IXA7C9ZN03; Halin;; Dimetane (TN); Prestwick_913; 3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate; Opera_ID_399; 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1); Dexbrompheniramine maleate;; Brompheniramine maleate CRS; (y)-Brompheniramine maleate; (?)-Brompheniramine maleate; 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-2-butenedioate (1:1); SCHEMBL41913; MLS001148196; SPECTRUM1503985; orb1223488; orb1310837; orb3139366; CHEMBL1200961; (A+/-)-Brompheniramine maleate; HY-B0480R; SRGKFVAASLQVBO-BTJKTKAUSA-N; HMS1569O12; HMS1922O16; HMS2093O07; HMS2096O12; HMS2230I21; HMS2234D14; HMS3260J03; HMS3884J10; HMS5081J07; Pharmakon1600-01503985; gamma-(4-Bromophenyl)-N,N-dimethyl-2-pyridinepropanamine Maleate; HY-B0480; MSK10144; Tox21_500201; (+/-)-Brompheniramine maleate 100 microg/mL in Acetonitrile:Methanol; Brompheniramine (maleate) (Standard); CCG-39068; EBC-80064; NSC758652; (+-)-2-p-Bromo-alpha-2-(dimethylamino)ethylbenzylpyridine maleate (1:1); AKOS015855858; Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1); AC-1311; BROMPHENIRAMINE MALEATE [MART.]; BROMPHENIRAMINE MALEATE [VANDF]; FB19341; LP00201; NSC 758652; 2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-butenedioate (1:1); BROMPHENIRAMINE MALEATE [USP-RS]; BROMPHENIRAMINE MALEATE [WHO-DD]; NCGC00093676-01; NCGC00093676-02; NCGC00093676-03; NCGC00093676-04; NCGC00093676-05; NCGC00260886-01; AS-14101; DA-61905; SMR000653459; SY066720; B7058; BROMPHENIRAMINE MALEATE [EP IMPURITY]; BROMPHENIRAMINE MALEATE [ORANGE BOOK]; EU-0100201; NS00076241; SW197031-3; BROMPHENIRAMINE MALEATE [EP MONOGRAPH]; B 2390; BROMPHENIRAMINE MALEATE [USP MONOGRAPH]; C77353; D00663; ( inverted question mark)-Brompheniramine maleate; BIPHETAP COMPONENT BROMPHENIRAMINE MALEATE; DIMETAPP COMPONENT BROMPHENIRAMINE MALEATE; BROMANATE COMPONENT BROMPHENIRAMINE MALEATE; BROMATAPP COMPONENT BROMPHENIRAMINE MALEATE; BROMFED-DM COMPONENT BROMPHENIRAMINE MALEATE; DIMETANE-DC COMPONENT BROMPHENIRAMINE MALEATE; DIMETANE-DX COMPONENT BROMPHENIRAMINE MALEATE; SR-01000003057-2; SR-01000003057-4; SR-01000003057-5; SR-01000003057-8; ( inverted exclamation markA)-Brompheniramine maleate; BROMANATE DC COMPONENT BROMPHENIRAMINE MALEATE; BROMANATE DM COMPONENT BROMPHENIRAMINE MALEATE; MYPHETANE DC COMPONENT BROMPHENIRAMINE MALEATE; Q27105975; 2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate; Brompheniramine Maleate 1.0 mg/ml in Methanol (as free base); 1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate; 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate; 3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine;maleic acid; Brompheniramine maleate, United States Pharmacopeia (USP) Reference Standard; (+/-)-2-P-BROMO-.ALPHA.-2-(DIMETHYLAMINO)ETHYLBENZYLPYRIDINE MALEATE (1:1); 3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate; 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine (Z)-but-2-enedioic acid; Brompheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material; (2Z)-But-2-enedioic acid--3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (1/1); 2-PYRIDINEPROPANAMINE, .GAMMA.-(4-BROMOPHENYL)-N,N-DIMETHYL-, (+/-)-, (Z)-BUTENEDIOATE (1:1)Synonyms